Where Will Aurora Cannabis Be in 1 Year?
Nearly five years ago, Aurora Cannabis (NASDAQ: ACB) acquired medical marijuana company MedReleaf in an all-stock deal valued at roughly 3.2 billion Canadian dollars ($2.4 billion). Today, Aurora Cannabis is a small fraction of that valuation. Aurora is showing signs of progress, but is it on the right track, and will the business be in a better place a year from now?